One study found that 32% of patients receiving IV glutathione experienced adverse events, including liver dysfunction and one case of anaphylaxis.[8] The FDA has issued warnings about contaminated IV glutathione causing hospitalizations.[9] Theres no long-term safety data for ongoing IV use
A modification of the assay developed for flavoproteins has been reported and was utilized here 51
Unknown Long-Term Safety : No longitudinal human data exist on the effects of prolonged BPC-157 use
However, increasing oral supplement doses (within safe limits) while awaiting medical review is generally considered safe, as B12 has very low toxicity and excess is excreted through the kidneys
DOSAGE Dosing for IGF-1 LR3 is based on anecdotal data and preclinical research, aiming for low-dose, infrequent administration due to the compound's potency and long half-life
Qian S, Liu J, Liao W, Wang F